This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent. Top assignee: Olipass Corporation. Active years: 2021-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2022
Title: The Innovative Contributions of Hyun Ju Jeon
Introduction: Hyun Ju Jeon is a prominent inventor based in Yongin-si, South Korea. With two patented innovations to her name, she has made significant strides in the field of biotechnology. Her work primarily focuses on developing peptide nucleic acid derivatives that have the potential to address various medical conditions.
Latest Patents: Jeon's latest patents include the "SNAP25 antisense oligonucleotides" and the "SCN9A antisense pain killer". The SNAP25 antisense oligonucleotides focus on providing peptide nucleic acid derivatives that target a 3' splice site of the human SNAP25 pre-mRNA. This innovation induces specific splice variants of the human SNAP25 mRNA in cells, presenting a safe treatment option for dermatological conditions that involve the expression of the human SNAP25 protein through topical administration. The SCN9A antisense pain killer, on the other hand, offers peptide nucleic acid derivatives that target the 3' splice site of exon 4 in human SCN9A pre-mRNA. This technology aims to induce splice variants of SCN9A mRNA that lack the SCN9A exon 4, which is crucial for addressing pain and conditions associated with Na1.7 activity.
Career Highlights: Currently, Hyun Ju Jeon is associated with Olipass Corporation, where she utilizes her expertise to innovate in the biotechnology sector. Her contributions greatly enhance the company's research and development initiatives, focusing on advanced therapeutic strategies.
Collaborations: Jeon's work is supported by her colleagues, including fellow inventors Daram Jung and Kangwon Jang, who collaborate with her to further advance their projects and innovations. Such teamwork fosters a dynamic environment that encourages inventive thinking and technological advancement.
Conclusion: With her groundbreaking patents and commitment to innovation, Hyun Ju Jeon exemplifies the spirit of inventiveness in the biotechnology field. Her work not only contributes to scientific knowledge but also holds the promise of improving the lives of many individuals facing health challenges. Through her collaborations and continued research, Jeon paves the way for future developments in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile